Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cannon

Showing results (691-700 of 934) with videos related to

Pageof 94
Sort By:
American Heart Journal|May 29, 1999
Methodologic drift in the assessment of TIMI grade 3 flow and its implications with respect to the reporting of angiographic trial results. The TIMI Study GroupC M Gibson, K A Ryan, M Kelley, et al.
Circulation|February 6, 2004
Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trialMarc S Sabatine, David A Morrow, Robert P Giugliano, et al.
Lancet (London, England)|November 23, 2006
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparisonChristopher P Cannon, Sean P Curtis, Garret A FitzGerald, et al.
The American Journal of Medicine|November 30, 2014
Temporal trends for secondary prevention measures among patients hospitalized with coronary artery diseaseDharam J Kumbhani, Gregg C Fonarow, Christopher P Cannon, et al.
Critical Pathways in Cardiology|March 5, 2009
Non-ST-elevation myocardial infarction patients who present during off hours have higher risk profiles and are treated less aggressively, but their outcomes are not worse: a report from Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation of the ACC/AHA Guidelines CRUSADE initiativeCharles V Pollack, Judd E Hollander, Anita Y Chen, et al.
JAMA|January 9, 2019
Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical TrialTracy Y Wang, Lisa A Kaltenbach, Christopher P Cannon, et al.
American Heart Journal|December 18, 2007
Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 studyC Michael Gibson, Sabina A Murphy, Yuri B Pride, et al.
Circulation. Cardiovascular Quality and Outcomes|February 27, 2014
Use of renin-angiotensin system blockers in acute coronary syndromes: findings from Get With the Guidelines-Coronary Artery Disease ProgramKevin R Bainey, Paul W Armstrong, Gregg C Fonarow, et al.
JACC. Cardiooncology|August 16, 2021
Prospective Evaluation of Malignancy in 17,708 Patients Randomized to Ezetimibe Versus Placebo: Analysis From IMPROVE-ITRobert P Giugliano, Baris Gencer, Stephen D Wiviott, et al.
Circulation|September 1, 2010
Late outcomes after carotid artery stenting versus carotid endarterectomy: insights from a propensity-matched analysis of the Reduction of Atherothrombosis for Continued Health (REACH) RegistrySripal Bangalore, Deepak L Bhatt, Joachim Röther, et al.
Pageof 94

Showing results (691-700 of 934) with videos related to

Sort By:
Pageof 94
American Heart Journal|May 29, 1999
Methodologic drift in the assessment of TIMI grade 3 flow and its implications with respect to the reporting of angiographic trial results. The TIMI Study GroupC M Gibson, K A Ryan, M Kelley, et al.
Circulation|February 6, 2004
Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trialMarc S Sabatine, David A Morrow, Robert P Giugliano, et al.
Lancet (London, England)|November 23, 2006
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparisonChristopher P Cannon, Sean P Curtis, Garret A FitzGerald, et al.
The American Journal of Medicine|November 30, 2014
Temporal trends for secondary prevention measures among patients hospitalized with coronary artery diseaseDharam J Kumbhani, Gregg C Fonarow, Christopher P Cannon, et al.
Critical Pathways in Cardiology|March 5, 2009
Non-ST-elevation myocardial infarction patients who present during off hours have higher risk profiles and are treated less aggressively, but their outcomes are not worse: a report from Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation of the ACC/AHA Guidelines CRUSADE initiativeCharles V Pollack, Judd E Hollander, Anita Y Chen, et al.
JAMA|January 9, 2019
Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical TrialTracy Y Wang, Lisa A Kaltenbach, Christopher P Cannon, et al.
American Heart Journal|December 18, 2007
Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 studyC Michael Gibson, Sabina A Murphy, Yuri B Pride, et al.
Circulation. Cardiovascular Quality and Outcomes|February 27, 2014
Use of renin-angiotensin system blockers in acute coronary syndromes: findings from Get With the Guidelines-Coronary Artery Disease ProgramKevin R Bainey, Paul W Armstrong, Gregg C Fonarow, et al.
JACC. Cardiooncology|August 16, 2021
Prospective Evaluation of Malignancy in 17,708 Patients Randomized to Ezetimibe Versus Placebo: Analysis From IMPROVE-ITRobert P Giugliano, Baris Gencer, Stephen D Wiviott, et al.
Circulation|September 1, 2010
Late outcomes after carotid artery stenting versus carotid endarterectomy: insights from a propensity-matched analysis of the Reduction of Atherothrombosis for Continued Health (REACH) RegistrySripal Bangalore, Deepak L Bhatt, Joachim Röther, et al.
Pageof 94